LIFETIME HEART & VASCULAR USES INNOVATIVE TREATMENT IN GILBERT FOR PATIENTS WITH
CHRONIC VENOUS INSUFFICIENCY (CVI)

4/2017, Gilbert, AZ – Lifetime Heart & Vascular is now using innovative technology for the treatment of chronic venous insufficiency (CVI), a disease that impacts 190 million people globally3 (more than 30 million Americans). Chronic venous insufficiency involves dysfunction of the valve within the vein, which helps control proper blood from.

Lifetime Heart & Vascular is using minimally invasive treatment technologies, such as the ClosureFast™ system. The ClosureFast™ system utilizes radiofrequency ablation (uniform heat) to seal off the problem vein so blood gets re-routed to another path. The unique procedure is proven effective in eliminating varicose veins and improving the appearance of the legs, allowing for a short, comfortable recovery and a quick return to everyday activities.

CVI, which can sometimes present as varicose veins, is a serious health issue for Arizona residents. In fact, less than 10 percent of people seek treatment for varicose veins. Many people with varicose veins believe their condition to be a cosmetic issue. However, if left untreated, varicose veins can progress to CVI, a serious disease that can cause leg pain, swelling, restlessness, skin damage and ulcers.

“As a progressive disease, it is important for patients to evaluate treatment options that demonstrate long-term effectiveness of the procedure given the chance of reoccurrence,” said Gautam Kedia, MD. “Data published in the British Journal of Surgery found that CVI patients treated with the ClosureFast™ procedure had strong closure rates and minimal treatment side effects at five years.”

With CVI and varicose veins, the valves in the leg veins that direct blood from the legs back toward the heart no longer function properly, causing blood to pool in the legs. Although this can occur at any time, increased age is a risk factor. Varicose veins and CVI also tend to be more prevalent in women who have been pregnant, in people who have a family history of CVI or those whose jobs require them to spend a great deal of time standing.

Studies show that the ClosureFast™ procedure is associated with lower rates of pain, bruising and complications, and a faster improvement in patients’ quality of life when compared to 980 nm laser ablation.

The procedure is generally conducted in a physician’s office or outpatient setting, and is covered by most health insurance. The average patient typically resumes normal activities within a few days following treatment, and most patients report a noticeable improvement in their symptoms within one to two weeks after the procedure.

For more information about treatment for CVI, please call us to schedule an evaluation.